Addus HomeCare sets Q2FY26 earnings release date

0 min read     Updated on 20 Jul 2026, 10:08 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Addus HomeCare Corporation announced it will release its Q2FY26 earnings on August 3, 2026. A conference call with senior leadership is scheduled for August 4, 2026, to discuss the results. The company serves over 62,000 patients across 24 states.

powered bylight_fuzz_icon
46111072

*this image is generated using AI for illustrative purposes only.

Addus HomeCare Corporation will release its financial results for the second quarter ended June 30, 2026, on Monday, August 3, 2026, after the market close. The company provides home care services, including personal care, hospice, and home health services, to approximately 62,750 patients across 24 states.

Conference Call Details

Addus HomeCare will host a conference call on Tuesday, August 4, 2026, at 9:00 a.m. Eastern Time. The call will feature Dirk Allison, Chairman and CEO; Brian Poff, Executive Vice President and CFO; and Heather Dixon, President and COO.

Access Information

Feature Details
Live Call Date August 4, 2026
Time 9:00 a.m. ET
Domestic Dial-in (833) 629-0620
International Dial-in (412) 317-1805
Passcode 7054130
Replay Availability Until midnight on August 11, 2026
Replay Dial-in (855) 669-9658
International Replay (412) 317-0088

A live broadcast of the call will be available in the Investor Relations section of the company's website at www.addus.com . An online replay will be accessible for one month starting approximately two hours after the live broadcast concludes.

What strategic initiatives is Addus pursuing to expand its patient base beyond the current 62,750?

How might changes in healthcare policy or reimbursement rates impact Addus's financial performance in the latter half of 2026?

What are the anticipated growth drivers for Addus's hospice and home health services in the upcoming quarters?

like18
dislike

Barclays raises Addus HomeCare price target to $96

0 min read     Updated on 09 Jul 2026, 08:30 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Barclays analyst Andrew Mok maintains an Underweight rating on Addus HomeCare (NASDAQ: ADUS) and raises the price target from $92 to $96, signaling a cautious outlook despite the valuation adjustment.

powered bylight_fuzz_icon
45154817

*this image is generated using AI for illustrative purposes only.

Barclays analyst Andrew Mok has maintained an Underweight rating on Addus HomeCare while raising the stock's price target to $96 from the previous $92. The revised target reflects an updated assessment of the company's valuation and market performance. Addus HomeCare is listed on the NASDAQ under the ticker symbol ADUS.

The rating indicates that the analyst expects the stock to underperform relative to the broader market or its sector peers. Despite the increase in the price target, the Underweight stance suggests caution regarding the company's near-term upside potential compared to other investment opportunities.

Rating and Target Details

The following table outlines the revised rating and price target set by Barclays:

Metric Value
Rating Underweight
Previous Price Target $92
New Price Target $96
Ticker NASDAQ: ADUS

Investors should note that price targets are projections based on current market conditions and analyst models, and they do not guarantee future performance.

What specific factors could drive Addus HomeCare's stock to reach the new $96 target despite the Underweight rating?

How might changes in healthcare policy or reimbursement rates impact Addus HomeCare's near-term performance?

What competitive pressures in the homecare sector could limit Addus HomeCare's upside potential relative to its peers?

like16
dislike